Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5082911
Max Phase: Preclinical
Molecular Formula: C20H11Cl2F3N2O3
Molecular Weight: 455.22
Molecule Type: Unknown
Associated Items:
ID: ALA5082911
Max Phase: Preclinical
Molecular Formula: C20H11Cl2F3N2O3
Molecular Weight: 455.22
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NC1c2ccc(Cl)cc2Oc2cc(Cl)ccc21)c1ccc(C(F)(F)F)[nH]c1=O
Standard InChI: InChI=1S/C20H11Cl2F3N2O3/c21-9-1-3-11-14(7-9)30-15-8-10(22)2-4-12(15)17(11)27-19(29)13-5-6-16(20(23,24)25)26-18(13)28/h1-8,17H,(H,26,28)(H,27,29)
Standard InChI Key: CSWLBAWVPPLEGS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 455.22 | Molecular Weight (Monoisotopic): 454.0099 | AlogP: 5.33 | #Rotatable Bonds: 2 |
Polar Surface Area: 71.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.37 | CX Basic pKa: | CX LogP: 4.07 | CX LogD: 4.06 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.55 | Np Likeness Score: -0.83 |
1. (2021) Modulators of hsd17b13 and methods of use thereof, |
Source(1):